标题
Immune checkpoint of B7-H3 in cancer: from immunology to clinical immunotherapy
作者
关键词
-
出版物
Journal of Hematology & Oncology
Volume 15, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2022-10-25
DOI
10.1186/s13045-022-01364-7
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Pediatric medulloblastoma express immune checkpoint B7-H3
- (2022) S. Li et al. Clinical & Translational Oncology
- DS-7300a, a DNA Topoisomerase I Inhibitor, DXd-based Antibody-Drug Conjugate Targeting B7-H3 Exerts Potent Antitumor Activities in Preclinical Models
- (2022) Michiko Yamato et al. MOLECULAR CANCER THERAPEUTICS
- B7‑H3 promotes the epithelial‑mesenchymal transition of NSCLC by targeting SIRT1 through the PI3K/AKT pathway
- (2022) Haixiu Liao et al. Molecular Medicine Reports
- Hallmarks of Cancer: New Dimensions
- (2022) Douglas Hanahan Cancer Discovery
- Co-deficiency of B7-H3 and B7-H4 identifies high CD8 + T cell infiltration and better prognosis in pancreatic cancer
- (2022) Shuping Si et al. BMC CANCER
- Dual checkpoint targeting of B7-H3 and PD-1 with enoblituzumab and pembrolizumab in advanced solid tumors: interim results from a multicenter phase I/II trial
- (2022) Charu Aggarwal et al. Journal for ImmunoTherapy of Cancer
- STRIVE-02: A first-in-human phase 1 trial of systemic B7H3 CAR T cells for children and young adults with relapsed/refractory solid tumors.
- (2022) Navin R. Pinto et al. JOURNAL OF CLINICAL ONCOLOGY
- Targeting B7-H3 in prostate cancer: Phase 2 trial in localized prostate cancer using the anti-B7-H3 antibody enoblituzumab, with biomarker correlatives.
- (2022) Eugene Shenderov et al. JOURNAL OF CLINICAL ONCOLOGY
- B7H3 CAR-T therapy in relation to tumor growth in skin tumor.
- (2022) Gang Hu et al. JOURNAL OF CLINICAL ONCOLOGY
- KIR3DL3-HHLA2 and TMIGD2-HHLA2 pathways: The dual role of HHLA2 in immune responses and its potential therapeutic approach for cancer immunotherapy
- (2022) Yang Li et al. Journal of Advanced Research
- The Alzheimer’s disease-associated gene TREML2 modulates inflammation by regulating microglia polarization and NLRP3 inflammasome activation
- (2022) Ying-Dong Zhang et al. Neural Regeneration Research
- miR-34a induces immunosuppression in colorectal carcinoma through modulating a SIRT1/NF-κB/B7-H3/TNF-α axis
- (2021) Fanyi Meng et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- B7-H3×4-1BB bispecific antibody augments antitumor immunity by enhancing terminally differentiated CD8+ tumor-infiltrating lymphocytes
- (2021) Gihoon You et al. Science Advances
- Preclinical Evaluation of B7-H3-Specific Chimeric Antigen Receptor T cells for the Treatment of Acute Myeloid Leukemia
- (2021) Eben I Lichtman et al. CLINICAL CANCER RESEARCH
- B7-H3 AND PD-L1 EXPRESSION ARE PROGNOSTIC BIOMARKERS IN A MULTI-RACIAL COHORT OF PATIENTS WITH COLORECTAL CANCER
- (2021) Wei Zhang et al. Clinical Colorectal Cancer
- Gastric Carcinomas with Stromal B7-H3 Expression Have Lower Intratumoural CD8+ T Cell Density
- (2021) Dita Ulase et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Targeting B7-H3 via chimeric antigen receptor T cells and bispecific killer cell engagers augments antitumor response of cytotoxic lymphocytes
- (2021) Jie Liu et al. Journal of Hematology & Oncology
- Targeting Radiation-Resistant Prostate Cancer Stem Cells by B7-H3 CAR T Cells
- (2021) Yida Zhang et al. MOLECULAR CANCER THERAPEUTICS
- Beyond immune checkpoint blockade: emerging immunological strategies
- (2021) Shawn P. Kubli et al. NATURE REVIEWS DRUG DISCOVERY
- Nivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell Carcinoma
- (2021) Toni K. Choueiri et al. NEW ENGLAND JOURNAL OF MEDICINE
- PLA2R1 promotes DNA damage and inhibits spontaneous tumor formation during aging
- (2021) Anda Huna et al. Cell Death & Disease
- Targeting cell-cycle machinery in cancer
- (2021) Jan M. Suski et al. CANCER CELL
- B7-H3, Negatively Regulated by miR-128, Promotes Colorectal Cancer Cell Proliferation and Migration
- (2021) Xiaomao Hu et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- CD276 expression enables squamous cell carcinoma stem cells to evade immune surveillance
- (2021) Cheng Wang et al. Cell Stem Cell
- Immune analysis of lymph nodes in relation to the presence or absence of tumor infiltrating lymphocytes in triple-negative breast cancer
- (2021) Ángela Quintana et al. EUROPEAN JOURNAL OF CANCER
- MiR-29c downregulates tumor-expressed B7-H3 to mediate the antitumor NK-cell functions in ovarian cancer
- (2021) Mengqi Deng et al. GYNECOLOGIC ONCOLOGY
- Are B7-H3 CAR-T cells the future universal treatment for pediatric brain tumors?
- (2021) Franck Bourdeaut NEURO-ONCOLOGY
- B7-H3 on breast cancer cell MCF7 inhibits IFN-γ release from tumour-infiltrating T cells
- (2021) Lili Shao et al. PATHOLOGY RESEARCH AND PRACTICE
- B7-H3 suppresses doxorubicin-induced senescence-like growth arrest in colorectal cancer through the AKT/TM4SF1/SIRT1 pathway
- (2021) Ruoqin Wang et al. Cell Death & Disease
- FUT8-mediated aberrant N-glycosylation of B7H3 suppresses the immune response in triple-negative breast cancer
- (2021) Yun Huang et al. Nature Communications
- Therapeutic Targeting of the Tumor Microenvironment
- (2021) Leire Bejarano et al. Cancer Discovery
- The expression of B7-H3 isoforms in newly diagnosed glioblastoma and recurrence and their functional role
- (2021) Marina Digregorio et al. Acta Neuropathologica Communications
- The Role of CD276 in Cancers
- (2021) Shengzhuo Liu et al. Frontiers in Oncology
- The Expression of Three Negative Co-Stimulatory B7 Family Molecules in Small Cell Lung Cancer and Their Effect on Prognosis
- (2021) Meng-jun Qiu et al. Frontiers in Oncology
- 620P MGC018, an anti-B7-H3 antibody-drug conjugate (ADC), in patients with advanced solid tumors: Preliminary results of phase I cohort expansion
- (2021) E. Shenderov et al. ANNALS OF ONCOLOGY
- Soluble B7-H3 in Ovarian Cancer and Its Predictive Value
- (2021) O. V. Kovaleva et al. BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE
- Evaluation of the role of soluble B7-H3 in association with membrane B7-H3 expression in gastric adenocarcinoma
- (2021) Lili Huang et al. Cancer Biomarkers
- Expression, regulation and clinical significance of B7-H3 on neutrophils in human gastric cancer
- (2021) Zheng-Yan Li et al. CLINICAL IMMUNOLOGY
- Phase 1 dose-escalation trial using convection-enhanced delivery of radiolabeled monoclonal antibody for diffuse intrinsic pontine glioma following external radiation therapy.
- (2021) Mark M. Souweidane et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase 1 dose escalation study of MGC018, an anti-B7-H3 antibody-drug conjugate (ADC), in patients with advanced solid tumors.
- (2021) Sekwon Jang et al. JOURNAL OF CLINICAL ONCOLOGY
- Immune checkpoint inhibitors in melanoma
- (2021) Matteo S Carlino et al. LANCET
- A membrane protein display platform for receptor interactome discovery
- (2021) Shengya Cao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Immune checkpoint B7‐H3 protein expression is associated with poor outcome and androgen receptor status in prostate cancer
- (2021) Caroline E. Nunes‐Xavier et al. PROSTATE
- Reduced B7-H3 expression by PAX3-FOXO1 knockdown inhibits cellular motility and promotes myogenic differentiation in alveolar rhabdomyosarcoma
- (2021) Takuyo Kanayama et al. Scientific Reports
- Fibronectin enhances tumor metastasis through B7‐H3 in clear cell renal cell carcinoma
- (2021) Jinjing Xie et al. FEBS Open Bio
- B7-H3/CD276: An Emerging Cancer Immunotherapy
- (2021) Wu-Tong Zhou et al. Frontiers in Immunology
- B7 score and T cell infiltration stratify immune status in prostate cancer
- (2021) Qianghua Zhou et al. Journal for ImmunoTherapy of Cancer
- Decreased m6A Modification of CD34/CD276(B7-H3) Leads to Immune Escape in Colon Cancer
- (2021) Yiran Zhou et al. Frontiers in Cell and Developmental Biology
- Targeting the immune checkpoint B7-H3 for next-generation cancer immunotherapy
- (2021) Chuan Liu et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- The role of B7-H3 in tumors and its potential in clinical application
- (2021) Ranran Feng et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- B7H3 expression and significance in idiopathic pulmonary fibrosis
- (2021) Chuling Fang et al. JOURNAL OF PATHOLOGY
- B7-H3 Suppresses Antitumor Immunity via the CCL2–CCR2–M2 Macrophage Axis and Contributes to Ovarian Cancer Progression
- (2021) Taito Miyamoto et al. Cancer Immunology Research
- Interleukin 20 receptor A expression in colorectal cancer and its clinical significance
- (2021) Rui Liu et al. PeerJ
- Overexpression of B7-H3 Is Associated With Poor Prognosis in Laryngeal Cancer
- (2021) Yixuan Li et al. Frontiers in Oncology
- B7-H3 as a Target for CAR-T Cell Therapy in Skull Base Chordoma
- (2021) Cheng Long et al. Frontiers in Oncology
- B7-H3: A promising therapeutic target for autoimmune diseases
- (2020) Yuting Chen et al. CELLULAR IMMUNOLOGY
- Efficacy of affibody-based ultrasound molecular imaging of vascular B7-H3 for breast cancer detection
- (2020) Rakesh Bam et al. CLINICAL CANCER RESEARCH
- Assessment of Metastatic and Reactive Sentinel Lymph Nodes with B7-H3-Targeted Ultrasound Molecular Imaging: A Longitudinal Study in Mouse Models
- (2020) Fengyang Zheng et al. MOLECULAR IMAGING AND BIOLOGY
- ‘Off-the-shelf’ allogeneic CAR T cells: development and challenges
- (2020) S. Depil et al. NATURE REVIEWS DRUG DISCOVERY
- B7-H3 and B7-H4 Expression in Breast Cancer and Their Association with Clinicopathological Variables and T Cell Infiltration
- (2020) Nah Ihm Kim et al. PATHOBIOLOGY
- B7-H3 promotes colorectal cancer angiogenesis through activating the NF-κB pathway to induce VEGFA expression
- (2020) Ruoqin Wang et al. Cell Death & Disease
- Overexpression of B7-H3 in α-SMA-Positive Fibroblasts Is Associated With Cancer Progression and Survival in Gastric Adenocarcinomas
- (2020) Shenghua Zhan et al. Frontiers in Oncology
- Bispecific Antibodies and Antibody–Drug Conjugates for Cancer Therapy: Technological Considerations
- (2020) Hyunbo Shim Biomolecules
- Locoregionally administered B7-H3-targeted CAR T cells for treatment of atypical teratoid/rhabdoid tumors
- (2020) Johanna Theruvath et al. NATURE MEDICINE
- B7-H3 Regulates Glioma Growth and Cell Invasion Through a JAK2/STAT3/Slug-Dependent Signaling Pathway
- (2020) Chuanhong Zhong et al. OncoTargets and Therapy
- The Immunoglobulin Superfamily Receptome Defines Cancer-Relevant Networks Associated with Clinical Outcome
- (2020) Erik Verschueren et al. CELL
- Blocking PD-1/PD-L1 by an ADCC enhanced anti-B7-H3/PD-1 fusion protein engages immune activation and cytotoxicity
- (2020) Yao Xu et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- B7-H3 immune checkpoint expression is a poor prognostic factor in colorectal carcinoma
- (2020) Zhao Lu et al. MODERN PATHOLOGY
- High B7‐H3 expression is linked to increased risk of prostate cancer progression
- (2020) Sarah Bonk et al. PATHOLOGY INTERNATIONAL
- B7-H3-Targeted CAR-T Cells Exhibit Potent Antitumor Effects on Hematologic and Solid Tumors
- (2020) Zongliang Zhang et al. Molecular Therapy-Oncolytics
- Evaluation of ductal carcinoma in situ grade via triple-modal molecular imaging of B7-H3 expression
- (2020) Sunitha Bachawal et al. npj Breast Cancer
- B7-H3 augments the pro-angiogenic function of tumor-associated macrophages and acts as a novel adjuvant target for triple-negative breast cancer therapy
- (2020) Nan Cheng et al. BIOCHEMICAL PHARMACOLOGY
- B7-H3: an attractive target for antibody-based immunotherapy
- (2020) Filippos Kontos et al. CLINICAL CANCER RESEARCH
- Preclinical Development of MGC018, a Duocarmycin-based Antibody-drug Conjugate Targeting B7-H3 for Solid Cancer
- (2020) Juniper A Scribner et al. MOLECULAR CANCER THERAPEUTICS
- Antibody–Drug Conjugates for Cancer Therapy
- (2020) Umbreen Hafeez et al. MOLECULES
- B7-H3 regulates KIF15-activated ERK1/2 pathway and contributes to radioresistance in colorectal cancer
- (2020) Yanchao Ma et al. Cell Death & Disease
- TLT2 Suppresses Th1 Response by Promoting IL-6 Production in Monocyte Through JAK/STAT3 Signal Pathway in Tuberculosis
- (2020) Jinai Li et al. Frontiers in Immunology
- NK-Cell-Mediated Targeting of Various Solid Tumors Using a B7-H3 Tri-Specific Killer Engager In Vitro and In Vivo
- (2020) Daniel A. Vallera et al. Cancers
- Cancer Metabolism: Phenotype, Signaling and Therapeutic Targets
- (2020) Jae Hyung Park et al. Cells
- Macrophage-based approaches for cancer immunotherapy
- (2020) Nicholas R. Anderson et al. CANCER RESEARCH
- B7H3-Directed Intraperitoneal Radioimmunotherapy With Radioiodinated Omburtamab for Desmoplastic Small Round Cell Tumor and Other Peritoneal Tumors: Results of a Phase I Study
- (2020) Shakeel Modak et al. JOURNAL OF CLINICAL ONCOLOGY
- Cell surface antigen profiling of pediatric brain tumors: B7-H3 is consistently expressed and can be targeted via local or systemic CAR T-cell delivery
- (2020) Dalia Haydar et al. NEURO-ONCOLOGY
- B7-H3 expression in upper tract urothelial carcinoma associates with adverse clinicopathological features and poor survival
- (2020) Yuichi Koyama et al. PATHOLOGY RESEARCH AND PRACTICE
- Cancer Stem Cells: The Architects of the Tumor Ecosystem
- (2019) Briana C. Prager et al. Cell Stem Cell
- Time for radioimmunotherapy: an overview to bring improvements in clinical practice
- (2019) O. Leaman Alcibar et al. Clinical & Translational Oncology
- CAR T cells targeting B7-H3, a Pan-Cancer Antigen, Demonstrate Potent Preclinical Activity Against Pediatric Solid Tumors and Brain Tumors
- (2019) Robbie G. Majzner et al. CLINICAL CANCER RESEARCH
- Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
- (2019) Jérôme Galon et al. NATURE REVIEWS DRUG DISCOVERY
- Expression and clinical significance of PD-L1, B7-H3, B7-H4 and TILs in human small cell lung Cancer (SCLC)
- (2019) Daniel Carvajal-Hausdorf et al. Journal for ImmunoTherapy of Cancer
- B7-H3 expression in Merkel cell carcinoma-associated endothelial cells correlates with locally aggressive primary tumor features and increased vascular density
- (2019) Phyu P Aung et al. CLINICAL CANCER RESEARCH
- Antitumor Responses in the Absence of Toxicity in Solid Tumors by Targeting B7-H3 via Chimeric Antigen Receptor T Cells
- (2019) Hongwei Du et al. CANCER CELL
- Affibody-Indocyanine Green Based Contrast Agent for Photoacoustic and Fluorescence Molecular Imaging of B7–H3 Expression in Breast Cancer
- (2019) Rakesh Bam et al. BIOCONJUGATE CHEMISTRY
- The anti-apoptotic effect on cancer-associated fibroblasts of B7-H3 molecule enhancing the cell invasion and metastasis in renal cancer
- (2019) Shuai Zhang et al. OncoTargets and Therapy
- B7-H3 promotes aerobic glycolysis and chemoresistance in colorectal cancer cells by regulating HK2
- (2019) Tongguo Shi et al. Cell Death & Disease
- B7-H3 modulates endothelial cell angiogenesis through the VEGF cytokine
- (2019) Huijun Lai et al. IMMUNOLOGIC RESEARCH
- The novel non-immunological role and underlying mechanisms of B7-H3 in tumorigenesis
- (2019) Xiangqi Zhou et al. JOURNAL OF CELLULAR PHYSIOLOGY
- A platform for extracellular interactome discovery identifies novel functional binding partners for the immune receptors B7-H3/CD276 and PVR/CD155
- (2019) Bushra Husain et al. MOLECULAR & CELLULAR PROTEOMICS
- p38 MAPK activation through B7-H3-mediated DUSP10 repression promotes chemoresistance
- (2019) Karine Flem-Karlsen et al. Scientific Reports
- B7-H3-redirected chimeric antigen receptor T cells target glioblastoma and neurospheres
- (2019) Dean Nehama et al. EBioMedicine
- Role of MYC-miR-29-B7-H3 in Medulloblastoma Growth and Angiogenesis
- (2019) Ian J. Purvis et al. Journal of Clinical Medicine
- mTOR-Dependent Stimulation of IL20RA Orchestrates Immune Cell Trafficking through Lymphatic Endothelium in Patients with Crohn’s Disease
- (2019) Federica Ungaro et al. Cells
- Tumor-expressed B7-H3 mediates the inhibition of antitumor T-cell functions in ovarian cancer insensitive to PD-1 blockade therapy
- (2019) Dongli Cai et al. Cellular & Molecular Immunology
- Inhibitory receptors and ligands beyond PD-1, PD-L1 and CTLA-4: breakthroughs or backups
- (2019) Lawrence P. Andrews et al. NATURE IMMUNOLOGY
- LncRNA NEAT1 sponges miR-214 to regulate M2 macrophage polarization by regulation of B7-H3 in multiple myeloma
- (2019) Yin Gao et al. MOLECULAR IMMUNOLOGY
- Astragaloside IV inhibits cell proliferation of colorectal cancer cell lines through down-regulation of B7-H3
- (2018) Shuxia Wang et al. BIOMEDICINE & PHARMACOTHERAPY
- Genetic and clinical characterization of B7-H3(CD276) expression and epigenetic regulation in diffuse brain glioma
- (2018) Zhiliang Wang et al. CANCER SCIENCE
- Intraoperative Resection Guidance with Photoacoustic and Fluorescence Molecular Imaging Using an Anti–B7-H3 Antibody-Indocyanine Green Dual Contrast Agent
- (2018) Katheryne E. Wilson et al. CLINICAL CANCER RESEARCH
- B7-H3 Negatively Modulates CTL-Mediated Cancer Immunity
- (2018) Kimio Yonesaka et al. CLINICAL CANCER RESEARCH
- The type 1 transmembrane glycoprotein B7-H3 interacts with the glycolytic enzyme ENO1 to promote malignancy and glycolysis in HeLa cells
- (2018) Jiahui Zuo et al. FEBS LETTERS
- Convection-enhanced delivery for diffuse intrinsic pontine glioma: a single-centre, dose-escalation, phase 1 trial
- (2018) Mark M Souweidane et al. LANCET ONCOLOGY
- 212 Pb-labeled B7-H3-targeting antibody for pancreatic cancer therapy in mouse models
- (2018) Benjamin B. Kasten et al. NUCLEAR MEDICINE AND BIOLOGY
- Roles of B7-H3 in Cervical Cancer and Its Prognostic Value
- (2018) Sai Han et al. Journal of Cancer
- Negative roles of B7-H3 and B7-H4 in the microenvironment of cervical cancer
- (2018) Sai Han et al. EXPERIMENTAL CELL RESEARCH
- Immunoregulatory protein B7-H3 regulates cancer stem cell enrichment and drug resistance through MVP-mediated MEK activation
- (2018) Zixing Liu et al. ONCOGENE
- B7-H3 promotes metastasis, proliferation, and epithelial-mesenchymal transition in lung adenocarcinoma
- (2018) Ting-Ting Yu et al. OncoTargets and Therapy
- Molecular imaging of T cell co-regulator factor B7-H3 with 89Zr-DS-5573a
- (2018) Ingrid Julienne Georgette Burvenich et al. Theranostics
- Myeloid cell-like transcript 2 is related to liver inflammation and the pathogenesis of hepatitis B via the involvement of CD8+T cell activation
- (2018) Jun-Chi Xu et al. CLINICAL AND EXPERIMENTAL MEDICINE
- Turning foes to friends: targeting cancer-associated fibroblasts
- (2018) Xueman Chen et al. NATURE REVIEWS DRUG DISCOVERY
- CD276 (B7-H3) Maintains Proliferation and Regulates Differentiation in Angiogenic Function in Late Endothelial Progenitor Cells
- (2018) YeonSung Son et al. STEM CELLS
- Early Detection of Hepatocellular Carcinoma in Patients with Hepatocirrhosis by Soluble B7-H3
- (2017) Long Zhao et al. JOURNAL OF GASTROINTESTINAL SURGERY
- B7-H3 is related to tumor progression in ovarian cancer
- (2017) Jingjing Zhang et al. ONCOLOGY REPORTS
- Central nervous system relapse of rhabdomyosarcoma
- (2017) Brian De et al. PEDIATRIC BLOOD & CANCER
- Immunoregulatory protein B7-H3 promotes growth and decreases sensitivity to therapy in metastatic melanoma cells
- (2017) Karine Flem-Karlsen et al. Pigment Cell & Melanoma Research
- Current insights into functions of phospholipase A2 receptor in normal and cancer cells: More questions than answers
- (2017) Olga Sukocheva et al. SEMINARS IN CANCER BIOLOGY
- B7-H3 promoted proliferation of mouse spermatogonial stem cells via the PI3K signaling pathway
- (2017) Xuedong Wei et al. Oncotarget
- B7-H3 promotes gastric cancer cell migration and invasion
- (2017) Yecheng Li et al. Oncotarget
- Spectroscopic Photoacoustic Molecular Imaging of Breast Cancer using a B7-H3-targeted ICG Contrast Agent
- (2017) Katheryne E. Wilson et al. Theranostics
- Immunoregulatory Protein B7-H3 Reprograms Glucose Metabolism in Cancer Cells by ROS-Mediated Stabilization of HIF1α
- (2016) Sangbin Lim et al. CANCER RESEARCH
- Development of DS-5573a: A novel afucosylated mAb directed at B7-H3 with potent antitumor activity
- (2016) Akiko Nagase-Zembutsu et al. CANCER SCIENCE
- TREM-like transcript 2 is stored in human neutrophil primary granules and is up-regulated in response to inflammatory mediators
- (2016) Kimberly A. Thomas et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Opposing roles of the triggering receptor expressed on myeloid cells 2 and triggering receptor expressed on myeloid cells-like transcript 2 in microglia activation
- (2016) Honghua Zheng et al. NEUROBIOLOGY OF AGING
- The PLA2R1-JAK2 pathway upregulates ERRα and its mitochondrial program to exert tumor-suppressive action
- (2016) A Griveau et al. ONCOGENE
- Therapy to target renal cell carcinoma using 131I-labeled B7-H3 monoclonal antibody
- (2016) Gongcheng Wang et al. Oncotarget
- Decreased expression of B7-H3 reduces the glycolytic capacity and sensitizes breast cancer cells to AKT/mTOR inhibitors
- (2016) Caroline E. Nunes-Xavier et al. Oncotarget
- B7-H3 promotes aggression and invasion of hepatocellular carcinoma by targeting epithelial-to-mesenchymal transition via JAK2/STAT3/Slug signaling pathway
- (2015) Fu-biao Kang et al. Cancer Cell International
- Breast Cancer Detection by B7-H3-Targeted Ultrasound Molecular Imaging
- (2015) S. V. Bachawal et al. CANCER RESEARCH
- Humanized Affinity-matured Monoclonal Antibody 8H9 Has Potent Antitumor Activity and Binds to FG Loop of Tumor Antigen B7-H3
- (2015) Mahiuddin Ahmed et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Low incidence of radionecrosis in children treated with conventional radiation therapy and intrathecal radioimmunotherapy
- (2015) Kim Kramer et al. JOURNAL OF NEURO-ONCOLOGY
- Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
- (2015) James Larkin et al. NEW ENGLAND JOURNAL OF MEDICINE
- B7-H3 Promotes Pathogenesis of Autoimmune Disease and Inflammation by Regulating the Activity of Different T Cell Subsets
- (2015) Liqun Luo et al. PLoS One
- Overexpression of B7-H3 augments anti-apoptosis of colorectal cancer cells by Jak2-STAT3
- (2015) Ting Zhang WORLD JOURNAL OF GASTROENTEROLOGY
- Ablation of B7-H3 but Not B7-H4 Results in Highly Increased Tumor Burden in a Murine Model of Spontaneous Prostate Cancer
- (2015) K. Kreymborg et al. Cancer Immunology Research
- Interim results of an ongoing Phase I, dose escalation study of MGA271 (Fc-optimized humanized anti-B7-H3 monoclonal antibody) in patients with refractory B7-H3-expressing neoplasms or neoplasms whose vasculature expresses B7-H3
- (2015) John Powderly et al. Journal for ImmunoTherapy of Cancer
- Expression of B7-H3, a Potential Factor of Tumor Immune Evasion in Combination with the Number of Regulatory T Cells, Affects Against Recurrence-Free Survival in Breast Cancer Patients
- (2014) N. Maeda et al. ANNALS OF SURGICAL ONCOLOGY
- B7-H3 was Highly Expressed in Human Primary Hepatocellular Carcinoma and Promoted Tumor Progression
- (2014) Feifei Wang et al. CANCER INVESTIGATION
- Aberrant expression of B7-H3 in gastric adenocarcinoma promotes cancer cell metastasis
- (2014) WEI DAI et al. ONCOLOGY REPORTS
- Hepatocellular carcinomas promote tumor-associated macrophage M2-polarization via increased B7-H3 expression
- (2014) FU-BIAO KANG et al. ONCOLOGY REPORTS
- Correlation between B7-H3 expression and matrix metalloproteinases 2 expression in pancreatic cancer
- (2013) Lihua Xu et al. Cancer Cell International
- PLA2R1 Mediates Tumor Suppression by Activating JAK2
- (2013) D. Vindrieux et al. CANCER RESEARCH
- B7-H3 Associated with Tumor Progression and Epigenetic Regulatory Activity in Cutaneous Melanoma
- (2013) Jinhua Wang et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Characterization of a Soluble B7-H3 (sB7-H3) Spliced from the Intron and Analysis of sB7-H3 in the Sera of Patients with Hepatocellular Carcinoma
- (2013) Weiwei Chen et al. PLoS One
- Structure and T Cell Inhibition Properties of B7 Family Member, B7-H3
- (2013) Vladimir Vigdorovich et al. STRUCTURE
- Silencing of B7-H3 increases gemcitabine sensitivity by promoting apoptosis in pancreatic carcinoma
- (2013) XIN ZHAO et al. Oncology Letters
- B7-H3 is expressed in human hepatocellular carcinoma and is associated with tumor aggressiveness and postoperative recurrence
- (2012) Tai-Wei Sun et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Development of an Fc-Enhanced Anti-B7-H3 Monoclonal Antibody with Potent Antitumor Activity
- (2012) D. Loo et al. CLINICAL CANCER RESEARCH
- Combination strategies to enhance antitumor ADCC
- (2012) Holbrook E Kohrt et al. Immunotherapy
- B7-H3, a potential therapeutic target, is expressed in diffuse intrinsic pontine glioma
- (2012) Zhiping Zhou et al. JOURNAL OF NEURO-ONCOLOGY
- Structural basis for receptor sharing and activation by interleukin-20 receptor-2 (IL-20R2) binding cytokines
- (2012) N. J. Logsdon et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- B7-H3 contributes to the metastatic capacity of melanoma cells by modulation of known metastasis-associated genes
- (2011) Christina Tekle et al. INTERNATIONAL JOURNAL OF CANCER
- TLT2 Potentiates Neutrophil Antibacterial Activity and Chemotaxis in Response to G Protein-Coupled Receptor-Mediated Signaling
- (2011) M. M. Halpert et al. JOURNAL OF IMMUNOLOGY
- Non-small Cell Lung Cancer Induces an Immunosuppressive Phenotype of Dendritic Cells in Tumor Microenvironment by Upregulating B7-H3
- (2011) Thomas Schneider et al. Journal of Thoracic Oncology
- Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
- (2011) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- B7–H3 Ligand Expression by Primary Breast Cancer and Associated With Regional Nodal Metastasis
- (2010) Takaaki Arigami et al. ANNALS OF SURGERY
- Enhancement of effector CD8+T-cell function by tumour-associated B7-H3 and modulation of its counter-receptor triggering receptor expressed on myeloid cell-like transcript 2 at tumour sites
- (2010) Hiroko Kobori et al. IMMUNOLOGY
- MicroRNA miR-29 Modulates Expression of Immunoinhibitory Molecule B7-H3: Potential Implications for Immune Based Therapy of Human Solid Tumors
- (2009) H. Xu et al. CANCER RESEARCH
- The M-type receptor PLA2R regulates senescence through the p53 pathway
- (2009) Arnaud Augert et al. EMBO REPORTS
- B7-H3 is a potent inhibitor of human T-cell activation: No evidence for B7-H3 and TREML2 interaction
- (2009) Judith Leitner et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Compartmental intrathecal radioimmunotherapy: results for treatment for metastatic CNS neuroblastoma
- (2009) Kim Kramer et al. JOURNAL OF NEURO-ONCOLOGY
- Soluble CD276 (B7-H3) is released from monocytes, dendritic cells and activated T cells and is detectable in normal human serum
- (2008) Guangbo Zhang et al. IMMUNOLOGY
- Triggering receptor expressed on myeloid cell-like transcript 2 (TLT-2) is a counter-receptor for B7-H3 and enhances T cell responses
- (2008) M. Hashiguchi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MMP production in human fibrosarcoma cells and their invasiveness are regulated by group IB secretory phospholipase A2 receptor-mediated activation of cytosolic phospholipase A2
- (2007) Michal Gorovetz Frontiers in Bioscience-Landmark
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now